Skip to content
Lower risk Medical device recall · FDA · Published August 31, 2020

Olympus Evis Exera II Bronchovideoscope (BF-Q180) Recall: Higher infection risk than other

Olympus recalls all Evis Exera II Bronchovideoscopes (BF-Q180) due to higher patient infection rates compared to other OMSC models. No 510(k) clearance was issued for this device.

🇺🇸 FDA recall #Z-3017-2020Medical deviceOlympus ›
Take action

Contact the company

Recalling firmOlympus Corporation of the Americas3500 Corporate Pkwy, PO Box 610 · Center Valley, PA 18034-0610
✎ GovInfoNow plain-language explainer

Olympus is recalling all Evis Exera II Bronchovideoscopes (BF-Q180) because they lack 510(k) clearance and have been linked to higher infection rates than other Olympus bronchoscopes. This affects medical professionals using the device during procedures. Read more at govinfonow.com/recall/64394-olympus-evis-exera-ii-bronchovideoscope-bf-q180-recall-higher-infection.

Source Summary by GovInfoNow · govinfonow.com/recall/64394-olympus-evis-exera-ii-bronchovideoscope-bf-q180-recall-higher-infection · Updated August 19, 2026 · FDA enforcement record: FDA #Z-3017-2020

Cite this page

“Olympus Evis Exera II Bronchovideoscope (BF-Q180) Recall: Higher infection risk than other.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/64394-olympus-evis-exera-ii-bronchovideoscope-bf-q180-recall-higher-infection. Based on FDA recall #Z-3017-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3017-2020%22&limit=1).

The FDA announced on Aug. 31, 2020, that Olympus Corporation of the Americas is recalling all serial numbers of the Evis Exera II Bronchovideoscope Olympus BF Type Q180 (BF-Q180) because the device lacks required 510(k) clearance and is linked to higher patient infection rates. The recall involves 5,813 devices distributed worldwide.

How to tell if you have it

  • Brand: Olympus
  • Product: Evis Exera II Bronchovideoscope Olympus BF Type Q180 (BF-Q180)
  • Serial numbers: All serial numbers

The hazard

The BF-Q180 bronchoscope is being recalled because it does not have a 510(k) clearance, and the device is associated with a higher rate of patient infections than other comparable OMSC bronchoscopes.

Context

GovInfoNow's records show Olympus Corporation of the Americas has 133 other recalls on record since 2017-08-18. Other recent recalls include an Olympus Tripp-Lite P580-025 DisplayPort Cable recalled on 2026-08-27 for potential video dropout, and an Olympus M3 Gold Autoclavable Lateral Telescope recalled on 2026-08-24 due to sterilization parameter discrepancies. Other recent recalls of similar products include Medline's recall of Olympus Biopsy Kits on 2026-02-16 for risk of foreign body in patient airway and Medline's recall of Olympus Biopsy Valves on the same date for the same risk.

How to tell if you have this one

Check for the model name 'Olympus BF Type Q180 (BF-Q180)' on the device. All serial numbers are affected by this recall.

  • Brand
    Olympus
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Device Details

    Identify the model name and serial number to confirm if your device is affected.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide and International.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 3.5 years after the firm started it.

1. Firm started the recall: Aug 31, 202012. FDA classified it Class II: Sep 25, 202023. Published in FDA’s Enforcement Report: Oct 7, 202034. FDA terminated the recall: Feb 14, 2024420202024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-3017-2020 (August 31, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-3017-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA